Who shouldn't take hormone therapy?

Why this question matters so much

Hormone therapy is the most effective treatment for hot flashes and night sweats, and The Menopause Society notes that for most healthy women who start within 10 years of menopause or before age 60, benefits generally outweigh risks for bothersome symptoms. Being turned away for the wrong reason can mean years of avoidable symptoms.

At the same time, there are real situations where estrogen carries too much risk. A good assessment separates the two.

The genuine contraindications to systemic estrogen

The Menopause Society lists these as reasons hormone therapy is generally not used:

• Breast cancer, current or past.
• Endometrial (uterine) cancer. A progestogen alone may sometimes be an option; this is a specialist conversation.
• Unexplained vaginal bleeding, which needs investigation before any hormones.
• Liver disease.
• A history of blood clots in the legs or lungs.
• Cardiovascular disease, such as a prior heart attack or stroke.

'Not now' versus 'never'

Some of these are temporary. Unexplained bleeding is a reason to investigate first; once a benign cause is found and treated, hormone therapy may be fine. Uncontrolled blood pressure is a reason to get it under control first. Pregnancy, which is possible in perimenopause, obviously needs to be excluded.

Others are usually permanent, such as a personal history of breast cancer. Even then, vaginal estrogen for genitourinary symptoms may be discussed with an oncologist.

Common reasons that often aren't contraindications

• Being over 60 or more than 10 years past menopause. Risks rise with age and time since menopause, so the decision needs more care, but age alone isn't an absolute bar. The Menopause Society says there's no set time to stop.
• A family history of breast cancer. It's part of your risk assessment, but it's not the same as a personal history.
• Well-controlled high blood pressure. Transdermal estrogen is often preferred.
• Migraine, including with aura. It calls for care with the route and dose rather than automatic refusal; transdermal estradiol is usually favored.
• Fibroids or endometriosis, which may affect the choice of regimen.
• Diabetes, where transdermal estrogen is often preferred.
• Smoking. It raises clot and heart risk and is a strong reason to quit, and it shapes route choice.

Why the route of estrogen changes the picture

Estrogen taken by mouth passes through the liver before reaching the rest of the body, which affects the production of clotting proteins and other substances. Estrogen through the skin, as a patch, gel or cream, enters the bloodstream directly. The Menopause Society notes that oral hormone therapy raises blood clot risk and that transdermal estrogen may carry a lower clot risk.

That's why the answer for a woman with a clot-related concern, migraines, high blood pressure or diabetes is often 'transdermal, carefully,' rather than a flat no.

What changed in 2026

In February 2026, FDA approved labeling changes for menopausal hormone therapy products that removed boxed-warning statements about cardiovascular disease, breast cancer and probable dementia. FDA cited evidence that women who start hormone therapy within 10 years of menopause onset, generally before 60, have lower all-cause mortality and fewer fractures.

The label change doesn't mean hormone therapy is risk-free. Stroke and clot risks remain, and the National Cancer Institute notes that estrogen plus progestin increases breast cancer risk. It does mean decisions can be based on your individual risks rather than blanket warnings.

Vaginal estrogen is a different conversation

Low-dose vaginal estrogen treats dryness, painful sex and some urinary symptoms. The Menopause Society notes very little is absorbed into the bloodstream, so its risks are much lower than systemic therapy. Many women who can't use systemic estrogen can still discuss vaginal estrogen, though women with a history of breast cancer should involve their oncology team.

If systemic hormone therapy isn't right for you

• Non-hormonal prescription medicines for hot flashes.
• Cognitive behavioral therapy, which can reduce how much symptoms disrupt your life.
• Local vaginal therapies for genitourinary symptoms.
• Practical steps: a cooler bedroom, layered clothing, and less alcohol and smoking.
• Checking for other causes of similar symptoms, such as thyroid problems, iron deficiency or sleep apnea.

How HealifyMD decides

Your clinician reviews your bleeding history, clot and heart history, blood pressure, migraines, cancer history and family history before recommending anything. Hormone Therapy for Women at HealifyMD is listed at $349 for the first month, then $99/month, with estradiol (topical, cream or patch), estriol vaginal cream and progesterone included in the hormone therapy program rather than priced separately. The first month includes the evaluation and baseline labs, and pricing is confirmed at your eligibility review. Some of these, such as compounded estradiol cream, estriol vaginal cream and compounded progesterone, are compounded medications: they are not FDA-approved, FDA doesn't verify their safety, effectiveness or quality, and they aren't equivalent to branded products.